Opportunity Information: Apply for PAR 19 153
The National Institutes of Health (NIH) funding opportunity PAR 19-153 supports early-stage research on end-of-life and palliative care needs for adolescents and young adults (AYA) living with serious, advanced illnesses. In this announcement, AYA is defined as ages 12 through 24, consistent with World Health Organization and CDC definitions. The main goal is to build knowledge about what young people in this age range want and need when facing life-limiting disease, how they think about and make decisions, and which palliative or end-of-life care approaches best support them and the people close to them. The FOA places special emphasis on the fact that AYA experiences are not simply a younger version of adult illness or an older version of pediatric illness; this group often faces a unique mix of developmental, family, social, educational, and identity-related challenges that shape how care should be delivered.
The research scope is broad but centered on two connected themes. First, it encourages studies that directly examine AYA perspectives, priorities, wishes, communication preferences, and decision-making processes as illness progresses. That can include how AYA want to talk about prognosis, what matters most to them in terms of quality of life, how they balance independence with family involvement, and what they need from clinicians to feel heard and respected. Second, it invites research on specific end-of-life and palliative care (EOLPC) models designed to address the full range of AYA needs, including physical symptoms and comfort, psychological distress, spiritual concerns or meaning-making, and social needs such as relationships, school or work disruption, peer connections, and caregiver dynamics. The intent is to support evidence development around care models that work in real settings and that better align clinical care with what AYA patients and their families actually value.
This is an R21 mechanism, meaning it is meant for exploratory or developmental projects that can generate foundational data, pilot test approaches, refine measures, or establish feasibility for larger future studies. The FOA is labeled “Clinical Trial Optional,” which generally means applicants may propose studies that include clinical trial elements if appropriate, but a clinical trial is not required. That flexibility allows the opportunity to fund a range of designs, from observational and qualitative research that captures lived experiences and decision pathways, to pilot interventions or care delivery strategies that could later be scaled up or tested in larger trials.
Key logistical details from the source information include that the activity areas fall under education and health, with CFDA numbers 93.361 and 93.399. The award ceiling listed is $200,000, positioning it as a smaller, targeted grant suited for hypothesis development, early model testing, or building preliminary evidence. The opportunity is categorized as a discretionary grant program administered by NIH. The original closing date shown is 2022-01-07, and the FOA record indicates a creation date of 2019-01-08, which is useful context for anyone checking current availability or looking for reissued or related announcements.
Eligibility is intentionally expansive to encourage participation from many types of organizations that can contribute to AYA serious-illness and palliative care research. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits both with and without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other entities. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This broad eligibility aligns with the reality that AYA palliative care touches many systems, including hospitals, hospices, community organizations, schools, and culturally specific or geographically focused institutions.
Overall, PAR 19-153 is aimed at strengthening the evidence base for how best to care for seriously ill adolescents and young adults as they approach end of life or require palliative support, with attention to the whole person and the surrounding family and caregiver network. The announcement signals NIH interest in research that does a better job capturing AYA voices, clarifying how decisions are made in the context of serious illness, and developing or refining palliative care models that address physical comfort while also responding to emotional health, spiritual concerns, relationships, and the social realities of being 12 to 24 while living with a life-threatening condition.Apply for PAR 19 153
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361, 93.399.
- This funding opportunity was created on 2019-01-08.
- Applicants must submit their applications by 2022-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01 Clinical Trial Optional)
Previous opportunity: Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 153
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 153) also looked into and applied for these:
| Funding Opportunity |
|---|
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Apply for PAR 19 150 Funding Number: PAR 19 150 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Apply for PAR 19 149 Funding Number: PAR 19 149 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) Apply for PAR 19 162 Funding Number: PAR 19 162 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R41/R42 Clinical Trial Optional) Apply for RFA DA 19 022 Funding Number: RFA DA 19 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R43/R44 Clinical Trial Optional) Apply for RFA DA 19 021 Funding Number: RFA DA 19 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trials Required) Apply for RFA CA 19 007 Funding Number: RFA CA 19 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,250,000 |
| Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/R44 - Clinical Trial Optional) Apply for RFA DA 19 033 Funding Number: RFA DA 19 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trials Not Allowed) Apply for RFA CA 19 008 Funding Number: RFA CA 19 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $320,000 |
| Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) Apply for RFA CA 19 033 Funding Number: RFA CA 19 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 - Clinical Trial Optional) Apply for RFA DA 19 032 Funding Number: RFA DA 19 032 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) Apply for RFA CA 19 032 Funding Number: RFA CA 19 032 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) Apply for RFA AI 19 003 Funding Number: RFA AI 19 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 19 169 Funding Number: PAR 19 169 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 19 168 Funding Number: PAR 19 168 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet) (Admin Supp Clinical Trial Not Allowed) Apply for PA 19 174 Funding Number: PA 19 174 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed) Apply for RFA CA 19 010 Funding Number: RFA CA 19 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 19 011 Funding Number: RFA CA 19 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 19 184 Funding Number: PAR 19 184 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 19 183 Funding Number: PAR 19 183 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed) Apply for PAR 19 194 Funding Number: PAR 19 194 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 153", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
